Re-examining prostate-specific antigen (PSA) density: defining the optimal PSA range and patients for using PSA density to predict prostate cancer using extended …

JS Jue, MP Barboza, NS Prakash, V Venkatramani… - Urology, 2017 - Elsevier
Objective To compare the predictive accuracy of prostate-specific antigen (PSA) density vs
PSA across different PSA ranges and by prior biopsy status in a prospective cohort …

Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D‐DIGE and MS

C Geisler, NT Gaisa, D Pfister, S Fuessel… - BioMed research …, 2015 - Wiley Online Library
This study was designed to identify and validate potential new biomarkers for prostate
cancer and to distinguish patients with and without biochemical relapse. Prostate tissue …

Magnetic resonance imaging-defined prostate-specific antigen density significantly improves the risk prediction for clinically significant prostate cancer on biopsy

NR Bhat, JM Vetter, GL Andriole, AS Shetty, JE Ippolito… - Urology, 2019 - Elsevier
Objective To evaluate the predictive value of magnetic resonance imaging (MRI)-defined
prostate-specific antigen (PSA) density and MRI interpretation for the detection of clinically …

Can prostate imaging reporting and data system version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4–10 ng/ml?

N Xu, YP Wu, DN Chen, ZB Ke, H Cai, Y Wei… - Journal of cancer …, 2018 - Springer
Purpose To explore the value of Prostate Imaging Reporting and Data System Version 2 (PI-
RADS v2) for predicting prostate biopsy results in patients with prostate specific antigen …

Biosensors based on stanniocalcin-1 protein antibodies thin films for prostate cancer diagnosis

R Ferreira, PA Ribeiro, AVM Canário, M Raposo - Biosensors, 2023 - mdpi.com
Prostate cancer is one of the most prevalent tumors in men, accounting for about 7.3% of
cancer deaths. Although there are several strategies for diagnosing prostate cancer, these …

[HTML][HTML] Significance of non-standardized magnetic resonance imaging abnormalities and subsequent targeted prostate cancer biopsy for pathologists: a retrospective …

Y Okubo, Y Yamamoto, H Terao, T Suzuki… - … -Research and Practice, 2022 - Elsevier
Prostate biopsy is essential in diagnosing prostate cancer. The Prostate Imaging-Reporting
and Data System (PI-RADS) and magnetic resonance imaging (MRI)-transrectal ultrasound …

Comparison of PSA-density of the transition zone and whole gland for risk stratification of men with suspected prostate cancer: A retrospective MRI-cohort study

AF Schneider, D Stocker, AM Hötker, D Eberli… - European journal of …, 2019 - Elsevier
Purpose To compare the correlation of transition zone prostate-specific antigen density
(TZPSAD) versus whole gland (WG) density (PSAD) with Gleason score. Methods In this …

Transitioning from transrectal to transperineal prostate biopsy using a freehand cognitive approach

A Honoré, CA Moen, P Juliebø‐Jones… - BJU …, 2024 - Wiley Online Library
Objectives To report a single‐centre experience of a complete transition from transrectal
(TR) to transperineal (TP) prostate biopsy under local anaesthesia using a freehand …

f/t PSA 与PSAD 对tPSA 灰区且直肠指检阴性前列腺癌诊断价值的Meta 分析

周刚, 彭境罗, 刘幸生, 姜庆 - 循证医学, 2015 - jebm.cn
目的系统评价在直肠指检阴性时, 总前列腺特异性抗原处于诊断灰区(4~ 10 ng/mL),
比较游离前列腺特异性抗原/总前列腺特异性抗原比值与前列腺特异抗原密度对前列腺癌的诊断 …

[PDF][PDF] 前列腺特异性抗原衍生体及前列腺癌高特异性生物标志研究现状

朱圣生, 刘向云, 孙祖越 - 中国药理学与毒理学杂志, 2013 - cjpt.magtechjournal.com
前列腺癌是男性泌尿系统常见的恶性肿瘤之一, 严重威胁患者生命, 影响患者生活质量,
且近年来前列腺癌患病率在我国呈显著增高趋势. 因此, 前列腺癌的早期诊断成为目前临床上 …